These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3389862

  • 1. Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.
    Smith PJ, Hindmarsh PC, Brook CG.
    Arch Dis Child; 1988 May; 63(5):491-4. PubMed ID: 3389862
    [Abstract] [Full Text] [Related]

  • 2. Methionyl human growth hormone in Turner's syndrome.
    Rongen-Westerlaken C, Wit JM, Drop SL, Otten BJ, Oostdijk W, Waal HA, Gons MH, Bot A, Van den Brande JL.
    Arch Dis Child; 1988 Oct; 63(10):1211-7. PubMed ID: 3196048
    [Abstract] [Full Text] [Related]

  • 3. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
    Barton JS, Gardineri HM, Cullen S, Hindmarsh PC, Brook CG, Preece MA.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
    [Abstract] [Full Text] [Related]

  • 4. Dose-response curves for treatment with biosynthetic human growth hormone.
    Darendeliler F, Hindmarsh PC, Brook CG.
    J Endocrinol; 1990 May; 125(2):311-6. PubMed ID: 2373980
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.
    De Muinck Keizer-Schrama S, Rikken B, Hokken-Koelega A, Wit JM, Drop S.
    Arch Dis Child; 1994 Jul; 71(1):12-8. PubMed ID: 8067786
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators.
    Rekers-Mombarg LT, Massa GG, Wit JM, Matranga AM, Buckler JM, Butenandt O, Chaussain JL, Frisch H, Leiberman E, Yturriaga R, Aarskog D, Chatelain PG, Colle M, Dacou-Voutetakis C, Delemarre-van de Waal HA, Girard F, Gosen JJ, Irle U, Jansen M, Jean R, Job JC, Kaar ML, Kollemann F, Lenko HL, Waelkens JJ.
    J Pediatr; 1998 Mar; 132(3 Pt 1):455-60. PubMed ID: 9544901
    [Abstract] [Full Text] [Related]

  • 8. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM, Rikken B, Wynne HJ, Hokken-Koelega AC, Wit JM, Bot A, Drop SL.
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [Abstract] [Full Text] [Related]

  • 9. Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Dutch Growth Hormone Working Group.
    Nienhuis HE, Rongen-Westerlaken C, Wit JM, Otten BJ, de Muinck Keizer-Schrama SM, Drayer NM, Delemarre-van de Waal HA, Vulsma T, Oostdijk W, Waelkens JJ.
    Horm Res; 1993 Apr; 39 Suppl 2():31-6. PubMed ID: 8359786
    [Abstract] [Full Text] [Related]

  • 10. Effect of growth hormone on short normal children.
    Hindmarsh PC, Brook CG.
    Br Med J (Clin Res Ed); 1987 Sep 05; 295(6598):573-7. PubMed ID: 3117236
    [Abstract] [Full Text] [Related]

  • 11. Two-year results of treatment with methionyl human growth hormone in children with Turner syndrome. Dutch Growth Hormone Working Group.
    Rongen-Westerlaken C, Fokker MH, Wit JM, De Muinck Keizer-Schrama SM, Otten BJ, Oostdijk W, Delemarre van den waal HA, Gons MH, Bot A.
    Acta Paediatr Scand; 1990 Sep 05; 79(6-7):658-63. PubMed ID: 2386058
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of hypophyseal dwarfism with biosynthetic growth hormone].
    Blümel P, Stögmann W.
    Wien Klin Wochenschr; 1989 Dec 22; 101(24):861-3. PubMed ID: 2623878
    [Abstract] [Full Text] [Related]

  • 13. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 22; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
    Rongen-Westerlaken C, van Es A, Wit JM, Otten BJ, De Muinck Keizer-Schrama SM, Drayer NM, Oostdijk W, Delemarre-vd Waal HA, Gons MH, Waelkens JJ.
    Am J Dis Child; 1992 Jul 22; 146(7):817-20. PubMed ID: 1496949
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H, Bechtold S, Schwarz HP.
    Eur J Med Res; 2000 Jul 19; 5(7):307-10. PubMed ID: 10903191
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The relationship between the response to growth hormone therapy and pre-treatment growth hormone secretory status.
    Hindmarsh PC, Smith PJ, Pringle PJ, Brook CG.
    Clin Endocrinol (Oxf); 1988 May 19; 28(5):559-63. PubMed ID: 3214947
    [Abstract] [Full Text] [Related]

  • 20. A decade of growth hormone treatment in girls with Turner syndrome in the UK. UK KIGS Executive Group.
    Betts PR, Butler GE, Donaldson MD, Dunger DB, Johnston DI, Kelnar CJ, Kirk J, Price DA, Wilton P.
    Arch Dis Child; 1999 Mar 19; 80(3):221-5. PubMed ID: 10325700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.